1. Home
  2. APVO vs JOB Comparison

APVO vs JOB Comparison

Compare APVO & JOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

21.7M

Sector

Health Care

ML Signal

HOLD

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.19

Market Cap

22.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
APVO
JOB
Founded
2016
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
22.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
APVO
JOB
Price
$1.07
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
210.2K
Earning Date
11-06-2025
12-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$108,752,000.00
Revenue This Year
N/A
$43.94
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.17
52 Week High
$298.00
$0.51

Technical Indicators

Market Signals
Indicator
APVO
JOB
Relative Strength Index (RSI) 33.26 50.86
Support Level $1.07 $0.18
Resistance Level $1.41 $0.19
Average True Range (ATR) 0.09 0.01
MACD -0.01 0.00
Stochastic Oscillator 13.28 96.63

Price Performance

Historical Comparison
APVO
JOB

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

Share on Social Networks: